Gsa Capital Partners LLP Iveric Bio, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$17.24 - $23.95 $1.12 Million - $1.56 Million
-64,985 Reduced 78.92%
17,363 $372,000
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $774,071 - $1.53 Million
82,348 New
82,348 $1.48 Million
Q3 2020

Nov 06, 2020
SELL
$4.01 - $6.29 $82,950 - $130,114
-20,686 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$3.06 - $6.6 $63,299 - $136,527
20,686 New
20,686 $105,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email